This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Related articles in JOP Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lyman, G. H Search for Related Content PubMed Articles by Lyman, G. H Social Bookmarking                            What's this?

Preventing Venous Thromboembolism in Cancer Patients: Can We Do Better?

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

Gary H Lyman, MD, MPH, FRCP(Edin)

On September 15, 2008, a Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism was put forward by the US Surgeon General. The association between cancer and thrombosis has been known for more than 140 years. Approximately one in five episodes of venous thromboembolism (VTE) occurs in patients with a diagnosis of cancer. In addition to the release of cytokines and procoagulants by tumors resulting in a hypercoagulable state, patients with cancer seem to fulfill the Virchow's Triad, which includes compromised functional status and blood vessel compression or invasion by tumors. The . . . [Click for More]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related articles in JOP:

Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?

Alpesh N. Amin, Jay Lin, Guiping Yang, and Stephen Stemkowski
JOP 2009 5: 159-164. [Abstract] [Full Text]